Transfer of Parecoxib and Its Primary Active Metabolite Valdecoxib via Transitional Breastmilk Following Intravenous Parecoxib Use After Cesarean Delivery: A Comparison of Naïve Pooled Data Analysis and Nonlinear Mixed-Effects Modeling